Amneal Pharmaceuticals Inc reports results for the quarter ended September 30 - Earnings Summary

• Amneal Pharmaceuticals Inc AMRX.OQ reported quarterly adjusted earnings of 16 cents​​ per share for the quarter ended September 30, lower than the same quarter last year, when the company reported EPS of 19 cents. The mean expectation of four analysts for the quarter was for earnings of 14 cents per share. Wall Street expected results to range from 12 cents to 15 cents per share.

• Revenue rose 13.3% to $702.47 million from a year ago; analysts expected $696.80 million.

• Amneal Pharmaceuticals Inc's reported EPS for the quarter was breakeven results​.

• The company reported a quarterly loss of $156 thousand.

• Amneal Pharmaceuticals Inc shares had risen by 3.5% this quarter and gained 41.8% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 9.1% in the last three months.​

• In the last 30 days, there have been no negative revisions of earnings estimates

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."

• The average consensus recommendation for the pharmaceuticals peer group is also "buy"

Wall Street's median 12-month price target for Amneal Pharmaceuticals Inc is $10.00

This summary was machine generated from LSEG data November 8 at 04:22 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)